Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II oxaliplatin + S-1 for advanced/recurrent gastric cancer (chemotherapy-naïve)
jRCT2080220365Phase 2
- Sponsor
- Yakult Honsha
- Start
- Mar 2007
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin and tegafur in gastric cancer (GC), sponsored by Yakult Honsha.
02
Drugs
oxaliplatintegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCT2080220365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220365.